Mahsa Soti Khiabani

Mahsa Soti Khiabani

Auto-generated profile, based on publicly available information

Mahsa Soti Khiabani

Department of Pediatrics, Children's Medical Center, Pediatric Center of Excellence, School of Medicine Tehran University of Medical Sciences Tehran Iran

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in International Journal of Pediatrics
Verified
Journal Article
Open access
SASina Azadnajafabad
Sina Azadnajafabad
FAFaraha Zahra Awan
Faraha Zahra Awan
BABahar Ashjaei
Bahar Ashjaei
HAHosein Alimadadi
Hosein Alimadadi
MKMahsa Soti Khiabani
Mahsa Soti Khiabani
Background: Acute appendicitis (AA) is the most prevalent surgical emergency in the pediatric population, with the complicated form leading to various adverse outcomes. Our study is aimed at evaluating the incidence and associated risk factors of complicated AA among children presenting with this condition. Methods: Employing a cross‐sectional design, we included all children suspected of having AA who were admitted to a tertiary pediatric center in Iran from 2020 to 2021. Pathologists examined all surgically removed appendices, and only cases with histopathological confirmation of AA were included. We classified AA into complicated and uncomplicated categories. We recorded and analyzed demographic, clinical, and laboratory data of patients admitted with AA. Analyzed laboratory parameters included white blood cell (WBC) count, neutrophil count and percentage, erythrocyte sedimentation rate (ESR), and C‐reactive protein (CRP). Results: The study comprised 98 pediatric patients with AA, including 60 males (61.2%) and 38 females (38.8%), with a median age of 9.0 (interquartile range: 7.0–11.0) years. Eighteen (18.4%) cases were diagnosed with complicated AA. Mean WBC count, neutrophil count, and CRP levels were significantly higher in patients with complicated AA ( p values: 0.048, 0.018, and 0.014, respectively). After adjusting for relevant clinical factors, CRP (odds ratio: 1.02 [95% CI: 1.00–1.04]), WBC count (1.18 [1.03–1.37]), and neutrophil count (1.23 [1.06–1.45)]) were significantly associated with complicated AA. Receiver operating characteristic (ROC) curve analysis indicated a CRP cut‐off of 19.5 mg/dL, with an area under the curve of 0.687 (95% CI: 0.551–0.823), a sensitivity of 72.2%, and a specificity of 68.4% for predicting complicated AA. Conclusions: Laboratory parameters, specifically WBC count, neutrophil count, and CRP levels, are significant independent predictors of complicated AA in pediatric patients. These findings could assist in the timely diagnosis and management of children suspected of having AA in clinical practice.

17 March 2024 in Iranian Journal of Parasitology
Verified
Journal Article
Open access
MKMahmoud Khodabandeh
Mahmoud Khodabandeh
EMElham Moradian
Elham Moradian
MSMaedeh Sarvari
Maedeh Sarvari
MKMahsa Soti Khiabani
Mahsa Soti Khiabani
Background: Black disease, also known as visceral leishmaniasis (VL), is a parasitic illness caused by various Leishmania species. The risk of morbidity and mortality increases with delayed diagnosis and treatment. Early VL diagnosis and fast appropriate treatment are critical issues in endemic areas. Methods: This study was a retrospective cross-sectional study to investigate the diagnostic and therapeutic course of patients admitted with the diagnosis of VL in the Children's Medical Center (CMC) Hospital, Tehran, Iran. All cases of VL in patients under the age of 18 hospitalized between the years 2012 to 2022 were enrolled. Results: Twenty-seven patients were enrolled with an average age of 28.13 months with the majority of females (51.8%). Common clinical signs were fever (96.2%) and splenomegaly (92.59%). However, lymphadenopathy was rare. The largest number of patients was from Tehran Province, followed by Ardabil, Khuzestan, Gilan, and Alborz provinces. The most common hematological abnormalities were anemia (85.1%) and thrombocytopenia (44.4%). In accordance with the treatment strategy, liposomal amphotericin B and amphotericin B deoxycholate were given to 11 and 5 patients, respectively. Eleven of them received glucantime. The average length of hospitalization for liposomal amphotericin B was 15.36 ± 12.49 days. In comparison with glucantime (18.38 ±10.26 days) and amphotericin B deoxycholate (20.20± 6.18 days), liposomal amphotericin B group hospitalization was shorter than others were. Conclusion: VL should be included in the differential diagnosis of any child who presents with fever, splenomegaly, and anemia. Concerning the treatment strategy in this study, liposomal amphotericin B had more efficiency and shorter hospitalization duration.

15 April 2023 in Iranian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
MKMahsa Soti Khiabani
Mahsa Soti Khiabani
HAHosein Alimadadi
Hosein Alimadadi
MAMohammad Reza Abdolsalehi
Mohammad Reza Abdolsalehi
MAMaryam Sotoudeh Anvari
Maryam Sotoudeh Anvari
: Reports of acute hepatitis with unknown origin in children have been published worldwide since April 2022. Due to the unfamiliar nature of the disease and the alarming trend of increasing reports worldwide, health workers must become aware of its diagnosis and treatment. Accordingly, the committee for developing guidelines for the Department of Pediatrics, Tehran University of Medical Sciences, prepared a clinical guideline for more efficient management of these patients. Due to the limited information about this disease, it has been tried to categorize and specify the required diagnostic and treatment measures based on the latest published data. Herein we express this algorithmic approach and diagnostic and therapeutic guidelines for acute hepatitis with unknown origin in children.

21 August 2024 in Iranian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
AKAzadeh Kiumarsi
Azadeh Kiumarsi
RDReza Mohamadhosseinzadeh Davatgari
Reza Mohamadhosseinzadeh Davatgari
MHMaryam Habibi
Maryam Habibi
MKMahsa Soti Khiabani
Mahsa Soti Khiabani
Introduction: Methimazole is considered the first-line antithyroid drug for Graves’ disease (GD) in children and adolescents. However, it can lead to severe adverse effects, such as agranulocytosis, which can result from direct drug toxicity or immune-mediated responses. This report aims to describe the clinical management of an adolescent with GD who developed agranulocytosis following methimazole administration. Case Presentation: A 13-year-old female, diagnosed with GD, developed neutropenia six months after starting methimazole. She was admitted with high-grade fever, sore throat, palpitations, fatigue, myalgia, and diarrhea. The treatment regimen included filgrastim, antibiotics, β-blockers, a solution of potassium iodide (SSKI), cholestyramine, and lithium. Within seven days, her absolute neutrophil count gradually improved, her fever subsided, her hyperthyroidism was controlled, and she was discharged. Discussion: Antithyroid drug-induced neutropenia represents a serious complication. In these patients, effective infection management, control of hyperthyroidism, and supportive measures to promptly increase the neutrophil count can reduce the associated morbidity and mortality. Conclusions: Close monitoring and awareness of risk factors, such as age, female sex, and higher doses of methimazole, may decrease the risk of agranulocytosis and its fatal outcomes. Alternative treatments to control hyperthyroidism during methimazole-induced agranulocytosis include β-blockade, potassium iodide solution (SSKI), cholestyramine, steroids, and lithium.

30 October 2023 in Journal of Kerman University of Medical Sciences
Verified
Journal Article
Open access
PDF file
RDReza Mohamad Hosein Zade Davatgari
Reza Mohamad Hosein Zade Davatgari
MKMahsa Soti Khiabani
Mahsa Soti Khiabani
PSParviz Shahmirzalou
Parviz Shahmirzalou
MHMaryam Habibi
Maryam Habibi
Sodium-glucose cotransporter-2 (SGLT-2) inhibitors are a new class of oral drugs used to treat type 2 diabetes (T2DM). EuGlycemic Diabetic Ketoacidosis (EuDKA) is associated with an almost normal level of blood glucose, causing a delay in its diagnosis and treatment. The diagnosis of EuDKA is a challenge for doctors due to its unusual manifestations. EuDKA is one of the rare complications associated with the use of SGLT-2 inhibitors, but it is serious and dangerous. Early diagnosis and treatment of EuDKA require the knowledge and precision of doctors so that they can quickly and safely restore the acid-base balance. EuDKA appears with a slight increase in blood glucose (less than the level defined in the diagnostic criteria for DKA), metabolic acidosis, and increase in the anion gap. Its manifestations are somewhat different from typical DKA. Patients with type 1 or 2 diabetes who present weakness, nausea and vomiting, and metabolic acidosis and are taking SGLT-2 inhibitors should be evaluated for the presence of urine and/or serum ketones. In this report, we reported a case of euglycemic DKA following the use of SGLT2 inhibitor and its treatment.

1 January 2025 in International Journal of Pediatrics
Verified
Journal Article
Open access
MKMahmoud Khodabandeh
Mahmoud Khodabandeh
ZJZahra Jam
Zahra Jam
ASAryan Banai Shahani
Aryan Banai Shahani
MKMahsa Soti Khiabani
Mahsa Soti Khiabani
Background: Cervical lymphadenitis is prevalent in children. Several viruses and bacteria can cause cervical lymphadenitis. Staphylococcus aureus and Streptococcus pyogenes are known to predominate as bacterial causes. Choosing the effective antibiotic regimen to treat cervical lymphadenitis is difficult because of temporal and geographical variations in its etiologies and antibiotic resistance. We aim to elucidate the etiologies, treatment, and outcomes of cervical lymphadenitis in children in Iran. Methods: A total of 113 patients admitted to the Children’s Medical Center in Iran were included in this retrospective cross‐sectional study. Patients under 18 years in medical records were evaluated for demographics, signs and symptoms, lymph node aspiration or surgical drainage culture and antibiogram results, type and duration of treatment, complications, treatment failure, and patient discharge instructions. Results: Patients’ mean age was 3.5 years (SD: 2.9; range: 3 months to 13 years), and 70 (62%) were male. Of 113 patients, 38 (34%) had a prior history of upper respiratory tract infection (URI), 2 (1.7%) had dental caries, 1 (0.9%) had Hodgkin’s lymphoma, and 72 (64.1%) patients did not have any accompanying illnesses in presentation. The most common clinical manifestation was neck swelling or erythema (99.1%), followed by fever (73%), neck pain (30%), and torticollis (9%). Twenty‐one (18.5%) patients underwent cervical lymph node aspiration, and 7 (6%) underwent surgical incision and drainage, of which 17 (61%) had a positive culture. Staphylococcus aureus was isolated in 16 (94%) cases. No positive culture was reported regarding fungi and acid‐fast bacilli. Regarding their antibiogram reports, the lowest resistance rates were to vancomycin, cotrimoxazole, and oxacillin (6% each), followed by clindamycin and erythromycin (12% each) and penicillin (94%). The mean duration of hospitalization was 6 days (SD: 3.2; range: 2–22 days). Thirty‐three (29%) patients underwent surgical drainage along with antibiotic therapy. Conclusion: Cervical lymphadenitis was prevalently accompanied by URI. Swelling and erythema in the neck were the most common clinical manifestations. The most common isolated organism was Staphylococcus aureus . We did not find Streptococci, which might be due to the beta‐lactam usage before hospital admission. Most of the patients were treated with clindamycin during hospitalization. However, resistance to clindamycin was higher than that of other antibiotics effective against Staphylococci and Streptococci, like oxacillin. We recommend considering this resistance pattern in choosing antibiotics to prevent treatment failure and reduce the need for surgery.